Stay updated on Gantenerumab in Early Alzheimer's Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.

Latest updates to the Gantenerumab in Early Alzheimer's Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedExpanded the Locations section with numerous new study sites across the US, Canada, Australia, Europe, and other regions, and removed several previous location blocks.SummaryDifference2%

- Check23 days agoNo Change Detected
- Check44 days agoChange DetectedThe page now includes a note that PubMed-derived publications are automatically filled and may not relate to the study, and the revision tag was updated to v3.3.2, while the old PubMed-derived publications wording and the v3.2.0 revision note were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check52 days agoChange DetectedRemoved the government funding lapse notice regarding NIH Clinical Center operations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check66 days agoChange DetectedNo significant changes detected in the Study Details page; only minor formatting updates observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check95 days agoChange DetectedUpdated version to v3.2.0 and added a government operating-status notice for NIH Clinical Center, directing users to cc.nih.gov and opm.gov.SummaryDifference1%

- Check102 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.1%

Stay in the know with updates to Gantenerumab in Early Alzheimer's Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Early Alzheimer's Disease Clinical Trial page.